Perspective · 28 Aug 2023
Conference abstractPublished 8 Oct 2015
Novel and innovative strategies for peptide based drug design against Alzheimer’s disease
Indian Institute of Technology Guwahati, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Alzheimer’s Disease (AD), a common amyloidosis, has no cure yet. Pathological investigations revealed existence of numerous plaques in the Alzheimer’s patientsâÂ?Â? brain composed of Amyloid-Ã?² (AÃ?²) peptides, derived from Amyloid Precursor Proteins (APPs). Although the mechanism of plaque formation is unknown, AD is believed to be caused by the aggregation of misfolded AÃ?² peptides. Ã?²-breaker peptides have been developed that disrupt amyloid aggregates (plaques) in vitro as well as in vivo. We have developed two novel and innovative strategies for Ã?²-breaker peptide design. First one is based on the concept of Ã?²-sheet breaker Ã?±/Ã?² hybrid peptides (BSBHps); and the second one on the concept of Ã?²-Breaker Di-Peptides (BBDPs). We have demonstrated that such well designed peptides are capable of inhibition of amyloid formation of AÃ?² peptide. Also, they disrupt preformed toxic fibrillar aggregates into non toxic species in vitro. Such peptides may be useful for designing novel drugs against diverse amyloidoses including Alzheimer’s disease, Parkinson’s disease and diabetes type II. Recent advancements in this direction of research will be discussed in the Pharma Summit-2015.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 8 Aug 2016
Functionalization of the dendron-based carrier system with ApoE-derived peptide for enhancing blood-brain barrier targeting and permeability of drug used in the treatment of Alzheimer’s disease
Conference abstract
Functionalization of the dendron-based carrier system with ApoE-derived peptide for enhancing bloodbrain barrier targeting and permeability of drug used in the treatment of Alzheimer s disease
Commentary · 26 Jun 2024
Advancing Therapeutics: Novel Advances in Alzheimer's Disease Drug Design
Conference abstract · 26 Jul 2018
Introducing novel potential drugs for Alzheimer’s disease via computer-aided design
More from this journal
The newest in Journal of Pharmaceutical Care & Health Systems.
Review article · 9 Jun 2025
Blood Fluid: The Unseen Currents That Bind Life and Death Together
Research article · 8 Jun 2025
Formulation and Antibacterial Evaluation of Acmella olaracea (Akarkara) Gummies Used for Toothache
Research article · 9 Apr 2025
Deep Vein Thrombosis: A Closer Look at a Silent Threat
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutical Care & Health Systems
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Bhubaneswar Mandal”

